JAGUAR HEALTH, INC. Preferred Stock, Liquidation Preference, Value
JAGUAR HEALTH, INC. (JAGX) had Preferred Stock, Liquidation Preference, Value of $12.74 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockLiquidationPreferenceValue · last filed 2019-11-14
- 2019-09-30: Preferred Stock, Liquidation Preference, Value $12.74M.
- 2019-06-30: Preferred Stock, Liquidation Preference, Value $12.74M.
- 2019-03-31: Preferred Stock, Liquidation Preference, Value $12.74M.
- 2018-12-31: Preferred Stock, Liquidation Preference, Value $9.20M.
| Period end | Preferred Stock, Liquidation Preference, Value |
|---|---|
| 2019-09-30 | $12.74M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $12.74M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $12.74M 10-Q · filed 2019-05-21 |
| 2018-12-31 | $9.20M 10-Q · filed 2019-11-14 |
| 2018-09-30 | $9.20M 10-Q · filed 2018-11-19 |
| 2018-06-30 | $9.20M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $9.20M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |